AGENT IDE Trial: Long-Term Results and Clinical Implications

In this video from CRT2026, Dr. Robert Yeh reviews key outcomes, durability of treatment, and safety data from the AGENT IDE trial highlighting how AGENT™ Coronary Drug-Coated Balloon (DCB) fits into today’s PCI landscape. Gain practical insights on patient selection, real-world applicability, and how these findings may shape future treatment strategies. Explore the AGENT IDE trial 3-year results and how AGENT Coronary DCB helps treat ISR lesions real world practice. Dive deeper into AGENT IDE trial data: https://qrco.de/bgp0e1 AGENT™ Drug-Coated Balloon Indications, Safety, and Warnings: https://qrco.de/AGENT1 ©2026 Boston Scientific Corporation or its affiliates. All rights reserved. All trademarks are the property of their respective owners. Rx Only. IC-2460507-AA